The clinical expression of AD is believed to begin decades before the onset of the disease, which is observed via the formation of specific AD pathology, amyloid-beta (Aβ) plaques between neurons, and the accumulation of intracellular neurofibrillary tangles composed of tau. This evidence concerns the gene MAPT and Alzheimer disease.